Format

Send to

Choose Destination
Acta Neurochir (Wien). 2016 Feb;158(2):313-8. doi: 10.1007/s00701-015-2657-4. Epub 2015 Dec 11.

Radiosurgical considerations for cavernous sinus hemangioma: long-term clinical outcomes.

Author information

1
Department of Neurosurgery, College of Medicine, Kyung Hee University, 1, Hoegi-dong, Dongdaemun-gu, Seoul, 130-702, Korea.
2
Department of Neurosurgery, College of Medicine, Kyung Hee University, 1, Hoegi-dong, Dongdaemun-gu, Seoul, 130-702, Korea. gknife@khmc.or.kr.

Abstract

BACKGROUND:

Cavernous hemangiomas are rare vascular tumors in the cavernous sinus. Cranial neuropathies induced by cavernous sinus hemangiomas (CSH) necessitate tumor reduction, but surgery is extremely difficult due to the abundant vascularization of the lesion. We studied the effectiveness and safety of Gamma Knife radiosurgery (GKRS) for CSH.

METHODS:

We performed a retrospective analysis of 25 patients with CSH who were treated by GKRS between March 1992 and December 2014. Age, sex, target volume, and irradiation dose were analyzed as prognostic factors for CSH treated by GKRS.

RESULTS:

Eleven (84.6 %) patients had tumor shrinkage within 12 months after GKRS. Two patients experienced tumor progression, but tumor size decreased over 2 years after GKRS. No patients had permanent complications, and all patients experienced symptomatic improvement. There were no significant factors that predicted the prognosis of CSH.

CONCLUSIONS:

The optimal treatment for CSH has been unclear; however, in this study, GKRS was an effective and safe treatment for CSH. Thus, GKRS may be a primary treatment for CSHs in high-risk surgery patients.

KEYWORDS:

Cavernous sinus; Gamma Knife radiosurgery; Hemangioma

PMID:
26658989
DOI:
10.1007/s00701-015-2657-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center